StonvexLoading…
StonvexStonvexStonvexCore line items from DLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-26 | Annual 2024 2024-09-27 | Annual 2023 2023-09-29 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $1.35B | $1.27B | $1.30B | $1.25B |
Operating Income | $264.96M | $258.33M | $215.75M | $206.60M |
Net Income | $255.02M | $261.82M | $200.66M | $184.09M |
EPS (Diluted) | $2.62 | $2.69 | $2.05 | $1.81 |
Total Assets | $3.23B | $3.11B | $2.98B | $2.69B |
Total Liabilities | $595.81M | $623.03M | $607.58M | $438.53M |
Cash & Equivalents | $701.89M | $482.05M | $745.36M | $620.13M |
Free Cash Flow OCF − CapEx | $435.85M | $297.25M | $336.74M | $270.65M |
Shares Outstanding | 97.48M | 97.33M | 97.73M | 101.98M |